Therefore, the effect of hypercortisolism on FGF23 and urinary phosphate excretion should be further evaluated in a prospective setting and all patients with CS should be evaluated for hypophosphatemia, especially when it concerns CS from ectopic ACTH production. This evidence concerns the gene FGF23 and adrenal gland hyperfunction.